NCT07837817Not yet recruiting
The Impact of a Daily Dietary Supplement on Glycemic Control in Individuals With Overweight or Obesity
Source: ClinicalTrials.gov · Last updated 24 Sept 2026
Brief summary (registry, in English)
This clinical trial will evaluate the efficacy of Metabolic Master Pack over a 90-day intervention period. Sixty adults will be randomized to receive either Metabolic Master Pack or placebo. Participants will wear continuous glucose monitors throughout the study, complete repeated blood collections, undergo DEXA body composition assessments, and complete dietary records. Results will provide high-quality evidence regarding the product's effects on glucose regulation and metabolic health.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 9 Sept 2026
- Start date
- Oct 2026
- Primary completion date
- Sept 2027
- Lead sponsor
- University of South Alabama
- Diseases
- Obesity
- NCT number
- NCT07837817
What you commit to
- Study type: Interventional
- Planned participants: 60
- From Oct 2026 to the primary completion date, Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking medications that impact metabolism
- Current congestive heart failure, angina, uncontrolled arrhythmia, symptoms indicative of an increased acute risk for a cardiovascular event, prior myocardial infarction or history of cardiomyopathy, coronary artery bypass grafting or angioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrent DVT).
- Resting systolic blood pressure of \>160 mmHg or resting diastolic blood pressure of \>100 mmHg. If medicated for blood pressure control, the medication dose needs to be stable for \>6 months.
Other illness
- History of metabolic/bariatric surgery.
- Report a current medical condition or treatment for a medical condition that could affect body weight or contradict engagement in any aspect of the outcome measures or interventions.
Other
- Report sustained weight loss of \>3% in the past 3 months.
- Females who are pregnant, have been pregnant within the past 6 months, or plan to become pregnant during the study period.
Who the study is looking for
- BMI 25-40 kg/m²
- Ability to provide informed consent
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.